ChemicalBook > CAS DataBase List > ELN 441958

ELN 441958

Product Name
ELN 441958
CAS No.
913064-47-8
Chemical Name
ELN 441958
Synonyms
CS-1805;ELN 441958;ELN441958 ,E0460;ELN-441958, 10 mM in DMSO;7-chloro-2-[3-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carbonyl)phenyl]-3H-isoindol-1-one;7-Chloro-2-[3-[[9-(pyridin-4-yl)-3,9-diazaspiro[5.5]undecan-3-yl]carbonyl]phenyl]-2,3-dihydroisoindol-1-one;1H-Isoindol-1-one, 7-chloro-2,3-dihydro-2-[3-[[9-(4-pyridinyl)-3,9-diazaspiro[5.5]undec-3-yl]carbonyl]phenyl]-;7-chloro-2-[3-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carbonyl)phenyl]-3H-isoindol-1-one ELN441958;low CNS exposure,ELN-441958,Inhibitor,anti-hyperalgesic,ELN441958,Bradykinin Receptor,inhibit,high oral bioavailability
CBNumber
CB82627797
Molecular Formula
C29H29ClN4O2
Formula Weight
501.02
MOL File
913064-47-8.mol
More
Less

ELN 441958 Property

Boiling point:
738.4±60.0 °C(Predicted)
Density 
1.37±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Soluble in DMSO
form 
Powder
pka
10.87±0.10(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-4807
Product name
ELN-441958
Purity
99.84%
Packaging
5mg
Price
$420
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0013895
Product name
ELN-441958
Purity
95.00%
Packaging
5MG
Price
$503.35
Updated
2021/12/16
ApexBio Technology
Product number
B5925
Product name
ELN441958
Packaging
5mg
Price
$551
Updated
2021/12/16
ChemScene
Product number
CS-4807
Product name
ELN-441958
Purity
99.84%
Packaging
10mg
Price
$600
Updated
2021/12/16
ChemScene
Product number
CS-4807
Product name
ELN-441958
Purity
99.84%
Packaging
50mg
Price
$1800
Updated
2021/12/16
More
Less

ELN 441958 Chemical Properties,Usage,Production

Uses

ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].

Biological Activity

eln441958 is a novel, potent and selective bradykinin b1 receptor antagonist with ki value of 0.26 nm [1].the bradykinin b1 receptor is a g-protein coupled receptor with principal ligand of bradykinin and plays an important role in chronic pain and inflammation [1].eln441958 is a novel, potent and selective bradykinin b1 receptor antagonist. in imr-90 lung fibroblast cell membranes, eln441958 competitively inhibited the binding of the agonist [3h]dakd to the human b1 receptor with ki value of 0.26 nm. in imr-90 cells expressing the native human b1 receptor, eln441958 concentration-dependently antagonized calcium mobilization induced by dakd with kb value of 0.12 nm. eln441958 is highly selective for b1 over b2 receptors. eln441958 failed to inhibit the calcium mobilization induced by b2-receptor agonist bk. eln441958 also inhibited human μ-, δ-, κ- opioid receptors and muscarinic m1 receptor with ki values of 0.13, 0.69, 1.5 and 0.37 μm, respectively. eln441958 is also an agonist at the δ-opioid receptor (ec50 = 0.76 μm) and μ-opioid receptor. in vitro, eln441958 exhibited good permeability and metabolic stability [1].in rats and rhesus monkeys, eln441958 exhibited high oral bioavailability and moderate plasma half-lives. in rhesus monkeys, eln441958 dose-dependently reduced the thermal hyperalgesia induced by carrageenan with ed50 value of ~3 mg/kg s.c [1].

in vivo

ELN-441958 (1-10 mg/kg; s.c.; once) dose-dependently reduces carrageenan-induced thermal hyperalgesia in a rhesus monkey tail-withdrawal model[1].
ELN-441958 (0-10 mg/kg; i.v. or p.o.) exhibits a favorable pharmacokinetic profile in the rat and rhesus monkey[1].

Animal Model:Adult male and female rhesus monkeys[1]
Dosage:1, 3, or 10 mg/kg
Administration:Subcutaneous injection, 30 min before carrageenan injection
Result:Increased the tail-withdrawal latencies in a dose-dependent manner.
Animal Model:Rhesus monkeys or Sprague-Dawley rats[1]
Dosage:2.5 or 10 mg/kg for rats, 1 mg/kg or 5 mg/kg for rhesus monkeys
Administration:Intravenous injection (2.5 mg/kg and 1 mg/kg) or oral administration (10 mg/kg and 5 mg/kg) (Pharmacokinetic Analysis)
Result:In rats: When dosed intravenously, showed a moderate volume of distribution (2.7 L/kg, approximately four times total body water) and a moderate clearance (0.96 L/h/kg, approximately 24% of hepatic blood flow). The terminal plasma half-life of this compound in rats was 1.7 h. When dosed orally, the concentrations increased to a maximum of 1.2 g/mL at 2 h after dosing. The oral availability was 57%.
In rhesus monkeys: When dosed intravenously, showed a moderate volume of distribution (2.7 L/kg) and a moderate clearance (0.49 L/h/kg, approximately 32% of hepatic blood flow). The terminal plasma half-life was 3.9 h. When dosed orally, the concentrations increased to a maximum of 3.6 g/mL at 3.3 h after dosing. The calculated oral bioavailability was greater than 100%.

References

[1]. hawkinson je, szoke bg, garofalo aw, et al. pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin b1 receptor antagonist eln441958, j pharmacol exp ther, 2007, 322(2): 619-630.

ELN 441958 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

ELN 441958 Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
ShangHai KenEn Chemical Technology Co., Ltd.
Tel
13120367189
Fax
021-50315529
Email
mychess007@163.com
Country
China
ProdList
1994
Advantage
55
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4827
Advantage
55
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
88915
Advantage
60
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9550
Advantage
58
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 18101056239
Email
3193328036@qq.com
Country
China
ProdList
29661
Advantage
68

913064-47-8, ELN 441958Related Search:


  • 7-chloro-2-[3-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carbonyl)phenyl]-3H-isoindol-1-one
  • 7-Chloro-2-[3-[[9-(pyridin-4-yl)-3,9-diazaspiro[5.5]undecan-3-yl]carbonyl]phenyl]-2,3-dihydroisoindol-1-one
  • ELN 441958
  • 7-chloro-2-[3-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carbonyl)phenyl]-3H-isoindol-1-one ELN441958
  • CS-1805
  • 1H-Isoindol-1-one, 7-chloro-2,3-dihydro-2-[3-[[9-(4-pyridinyl)-3,9-diazaspiro[5.5]undec-3-yl]carbonyl]phenyl]-
  • low CNS exposure,ELN-441958,Inhibitor,anti-hyperalgesic,ELN441958,Bradykinin Receptor,inhibit,high oral bioavailability
  • ELN-441958, 10 mM in DMSO
  • ELN441958 ,E0460
  • 913064-47-8
  • C29H29ClN4O2
  • Inhibitors